MGL-3196
MGL-3196-05
Phase 2 small_molecule completed
Quick answer
MGL-3196 for Non-alcoholic Steatohepatitis is a Phase 2 program (small_molecule) at Madrigal Pharmaceuticals EU Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Madrigal Pharmaceuticals EU Limited
- Indication
- Non-alcoholic Steatohepatitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed